Autolomous is enabling ATMP Manufacturers bring Cell and Gene Therapies to more patients. Using smart technology, we are driven to make this highly-specialised area of medicine deliverable, available and affordable.
Working with ATMP Manufacturers to drive “costs of goods” down, our bespoke software cuts huge amounts of administrative resource that supports the manufacturing process. As a result, more treatments will be able to happen simultaneously while enhancing quality assurance and security of the supply chain and data. The intuitive laboratory-friendly interface pushes data securely to a blockchain platform – the need for a traditional paper-trail is negated. All data is immutable, precise and trackable. The result means everyone in the value-chain is supported by a digital system, one that improves their efficiency and responsibilities.
We’re looking for new team members. Are you a forward-thinking-digitally-minded individual? Do you want to be part of a meaningful and value-orientated company? Get in touch!
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | aescuvest | aescuvest.... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 24.04.2024 | Autolomous and BioCentriq Partner to Speed Up Cell Therapy D... | Collaboration leverages cutting-edge digital platform to streamline development and manufacturing ac... | salamancap... |
| 22.04.2024 | Watch a New Episode of Advancements on Saturday, 4/27 at 8:0... | DMG Productions Tune in to Bloomberg to learn how technology and innovation are enabling a brighter ... | prweb.com/... |
| 10.08.2021 | Bringing immuno-oncology cell therapies to the masses – are ... | ucltf.co.u... |